Difference between revisions of "Caspofungin (Cancidas)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
|||
| Line 1: | Line 1: | ||
Lipopeptide antifungal, no known antineoplastic properties. | Lipopeptide antifungal, no known antineoplastic properties. | ||
| + | |||
| + | == Patient Drug Information== | ||
| + | *[https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/21227s015lbl.pdf Caspofungin (Cancidas) Package Insert]<ref>[https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/21227s015lbl.pdf Caspofungin (Cancidas) Package Insert]</ref> | ||
==Also known as== | ==Also known as== | ||
*'''Brand names:''' Cagin, Cancidas, Capsain, Caspogin, Caspoliv, Casponova, Guficap, Kabifungin, Letocan, Profung, Wofungin | *'''Brand names:''' Cagin, Cancidas, Capsain, Caspogin, Caspoliv, Casponova, Guficap, Kabifungin, Letocan, Profung, Wofungin | ||
| + | |||
| + | ==References== | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 10:28, 4 April 2021
Lipopeptide antifungal, no known antineoplastic properties.
Patient Drug Information
Also known as
- Brand names: Cagin, Cancidas, Capsain, Caspogin, Caspoliv, Casponova, Guficap, Kabifungin, Letocan, Profung, Wofungin